Published in Sex Weekly Plus, May 10th, 1999
"A prospective study of percutaneous transrectal US (TRUS)-guided cryotherapy was performed on 71 patients with T1-T3, N0, M0 prostatic cancer. Ten patients underwent two or more procedures. All cases were newly diagnosed and patients had no previous treatment for cancer. For all patients, TRUS biopsies were performed at five to six...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Sex Weekly Plus